??Effect of ondansetron in treatment of irritable bowel syndrome (IBS)

Phase 3

• Conditions: Irritable Bowel Syndrome with diarrhea.; Irritable bowel syndrome with diarrhea; K58.0

• Registration Number: IRCT20190703044084N2
• Lead Sponsor: Zanjan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Patients with irritable bowel syndrome with diarrhea predominance based on Rome III criteria
Age:Between 18-50 years

Exclusion Criteria

Pregnancy
Lactation
Dissatisfaction to be included in the study
Any sign and symptom of inflammatory bowel disease
Psychiatric drug use
Drugs Interaction with ondansetron including: p450 enzyme system inducers (carbamazepine, phenobarbital, phenytoin, dexamethasone, rifampicin) p450 enzyme system inhibitors (clarithromycin erythromycin ketoconazole) 3
History of any bowel surgery except appendectomy and cholecystectomy

Study & Design

• Study Type: interventional
• Study Design: Not specified